BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 98 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 4.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $210,000 | +311.8% | 200,000 | +566.7% | 0.08% | +315.8% |
| Q2 2019 | $51,000 | -49.5% | 30,000 | 0.0% | 0.02% | -56.8% |
| Q1 2019 | $101,000 | +14.8% | 30,000 | 0.0% | 0.04% | 0.0% |
| Q4 2018 | $88,000 | -52.4% | 30,000 | 0.0% | 0.04% | -42.1% |
| Q3 2018 | $185,000 | -16.3% | 30,000 | 0.0% | 0.08% | -26.2% |
| Q2 2018 | $221,000 | +31.5% | 30,000 | +50.0% | 0.10% | +14.4% |
| Q4 2017 | $168,000 | -27.3% | 20,000 | 0.0% | 0.09% | -37.1% |
| Q3 2017 | $231,000 | -1.3% | 20,000 | 0.0% | 0.14% | -14.4% |
| Q2 2017 | $234,000 | -5.3% | 20,000 | 0.0% | 0.17% | -20.1% |
| Q1 2017 | $247,000 | – | 20,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 220,000 | $5,069,000 | 3.43% |
| Perceptive Advisors | 1,046,402 | $24,109,000 | 2.02% |
| Redmile Group, LLC | 860,809 | $17,269,000 | 1.88% |
| Baker Brothers Advisors | 4,283,732 | $98,697,000 | 1.01% |
| RA Capital Management | 1,026,402 | $9,337,000 | 1.00% |
| Ghost Tree Capital, LLC | 75,000 | $1,728,000 | 0.83% |
| ACUTA CAPITAL PARTNERS, LLC | 45,750 | $1,054,000 | 0.71% |
| GREAT POINT PARTNERS LLC | 50,000 | $1,152,000 | 0.55% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 167,210 | $3,853,000 | 0.33% |
| EMERALD ADVISERS, LLC | 198,202 | $4,567,000 | 0.24% |